Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

ClinicalTrials.gov ID: NCT07685808

Public ClinicalTrials.gov record NCT07685808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Olatorepatide, a GLP-1/GIP Receptor Agonist, With Different Doses and Drug-Titration Algorithms in Participants Living With Overweight or Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will test an experimental drug called olatorepatide ("study drug") to determine how safe and effective this drug is compared to placebo and how easily the body can accept this drug at different doses and dosing schedules without causing side effects, as well as how the drug is processed in the body by participants with overweight or obesity but do not have diabetes. The study is looking at: * What side effects the study drug might cause * How much study drug is in the blood at different times * How well the study drug works * What effects the study drug may have on the body at different dosing schedules * If the body makes antibodies to the study drug as this may cause the study drug to not work as well

Study identification

NCT ID
NCT07685808
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 28, 2026 (Actual)
Primary completion
Jan 21, 2028 (Estimated)
Completion
Jan 21, 2028 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2028

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
AMR Clinical - Mobile Mobile Alabama 36608 Recruiting
Diablo Clinical Research - Flourish Research Walnut Creek California 94598 Recruiting
Chase Medical Research Waterbury Connecticut 06708 Recruiting
Alliance for Multispecialty Research (AMR) Clinical Miami Doral Florida 33172 Recruiting
AMR Clinical - Fort Myers Fort Myers Florida 33912 Recruiting
AGA Clinical Trials Hialeah Florida 33012 Recruiting
Flourish Research, Nature Coast Clinical Research Inverness Florida 34452 Recruiting
Flourish Research, Jacksonville Center for Clinical Research Jacksonville Florida 32216 Recruiting
K2 Medical Research Maitland LLC, Main Office Maitland Florida 32751 Recruiting
The IMA Group, IMA Clinical Research St. Petersburg St. Petersburg Florida 33704 Recruiting
Charter Research LLC - The Villages The Villages Florida 32162 Recruiting
Clinical Site Partners, LLC DBA Flourish Research Winter Park Florida 32789 Recruiting
Charter Research LLC - Chicago Chicago Illinois 60618 Recruiting
Flourish Research - Chicago Chicago Illinois 60625 Recruiting
AMR Clinical - Chicago Oak Brook Oak Brook Illinois 60523 Recruiting
AMR Clinical - Wichita Wichita Kansas 67207 Recruiting
AMR Clinical - Lexington Lexington Kentucky 40509 Recruiting
Velocity Clinical Research - Omaha Omaha Nebraska 68134 Recruiting
NYC Research Inc New York New York 10016 Recruiting
Rochester Clinical Research Rochester New York 14609 Recruiting
Tribe Clinical Research Greenville South Carolina 29607 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07685808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07685808 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →